Advertisement
Advertisement

GRDN

GRDN logo

Guardian Pharmacy Services, Inc.

26.99
USD
Sponsored
-2.51
-8.51%
Jan 16, 16:00 UTC -5
Closed
exchange

After-Market

27.17

+0.18
+0.67%

GRDN Earnings Reports

Positive Surprise Ratio

GRDN beat 1 of 5 last estimates.

20%

Next Report

Date of Next Report
Mar 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$396.93M
/
$0.22
Implied change from Q3 25 (Revenue/ EPS)
+5.17%
/
+46.67%
Implied change from Q4 24 (Revenue/ EPS)
+17.24%
/
+15.79%

Guardian Pharmacy Services, Inc. earnings per share and revenue

On Nov 10, 2025, GRDN reported earnings of 0.15 USD per share (EPS) for Q3 25, missing the estimate of 0.17 USD, resulting in a -13.49% surprise. Revenue reached 377.43 million, compared to an expected 361.23 million, with a 4.48% difference. The market reacted with a +5.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of 0.22 USD, with revenue projected to reach 396.93 million USD, implying an increase of 46.67% EPS, and increase of 5.17% in Revenue from the last quarter.
FAQ
For Q3 2025, Guardian Pharmacy Services, Inc. reported EPS of $0.15, missing estimates by -13.49%, and revenue of $377.43M, 4.48% above expectations.
The stock price moved up 5.04%, changed from $29.75 before the earnings release to $31.25 the day after.
The next earning report is scheduled for Mar 24, 2026.
Based on 6 analysts, Guardian Pharmacy Services, Inc. is expected to report EPS of $0.22 and revenue of $396.93M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement